IMPACT OF ETANERCEPT-METHOTREXATE THERAPY ON PATIENT-REPORTED OUTCOMES IN A RANDOMIZED CONTROLLED TRIAL IN MODERATELY ACTIVE RHEUMATOID ARTHRITIS PATIENTS

被引：0
|
作者：
Bird, P. [1 ]
Wollenhaup, J. [2 ]
Lee, S. -H. [3 ]
Szekanecz, Z. [4 ,5 ]
Neira, O. [6 ]
Hammond, C. [7 ]
Vlahos, B. [7 ]
Szumski, A. [7 ]
Koenig, A. S. [7 ]
Kotak, S. [8 ]
机构：
[1] Optimus Clin Res, Kogarah, NSW, Australia
[2] Schon Klinikum Eilbek, Hamburg, Germany
[3] Konkuk Univ Hosp, Seoul, South Korea
[4] Univ Debrecen, H-4012 Debrecen, Hungary
[5] Hlth Sci Ctr, Debrecen, Hungary
[6] Univ Chile, Hosp Salvador, Santiago, Chile
[7] Pfizer Inc, Collegeville, PA USA
[8] Pfizer Inc, New York, NY USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2013年 / 71卷
关键词：
D O I：
10.1136/annrheumdis-2012-eular.3422
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：633 / 633
页数：1
相关论文
共 50 条
  • [1] IMPACT OF ETANERCEPT-METHOTREXATE THERAPY ON PATIENT-REPORTED OUTCOMES IN MODERATELY ACTIVE RHEUMATOID ARTHRITIS (RA) PATIENTS OF EUROPE, LATIN AMERICA, AND ASIA
    Szekanecz, Z.
    Yen, J. H.
    Miranda, P.
    Szumski, A.
    Bananis, E.
    Kotak, S.
    Rahman, M.
    Tang, B.
    VALUE IN HEALTH, 2012, 15 (07) : A674 - A674
  • [2] IMPACT OF ETANERCEPT-METHOTREXATE THERAPY ON PATIENT-REPORTED OUTCOMES IN MODERATELY ACTIVE RHEUMATOID ARTHRITIS: AUSTRALIAN RESULTS FROM THE INDUCTION PERIOD OF PRESERVE TRIAL
    Nash, P.
    Hall, S.
    Bird, P.
    Bananis, E.
    Koenig, A.
    Szumski, A.
    Jones, H.
    Kotak, S.
    Witcombe, D.
    Thirunavukkarasu, K.
    INTERNAL MEDICINE JOURNAL, 2012, 42 : 12 - 13
  • [3] Impact Of Etanercept-Methotrexate Treatment Withdrawal On Patient-Reported Outcomes In Patients With Early Rheumatoid Arthritis (PRIZE Trial)
    Wiland, Piotr
    Combe, B.
    FitzGerald, Oliver M.
    Tahir, Hasan
    Gaylord, Stefanie
    Williams, Theresa
    Pedersen, Ronald
    Bukowski, Jack
    Vlahos, Bonnie
    Kotak, Sameer
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S1008 - S1009
  • [4] The Effect of Reduced or Withdrawn Etanercept-methotrexate Therapy on Patient-reported Outcomes in Patients with Early Rheumatoid Arthritis
    Wiland, Piotr
    Dudler, Jean
    Veale, Douglas
    Tahir, Hasan
    Pedersen, Ron
    Bukowski, Jack
    Vlahos, Bonnie
    Williams, Theresa
    Gaylord, Stefanie
    Kotak, Sameer
    JOURNAL OF RHEUMATOLOGY, 2016, 43 (07) : 1268 - 1277
  • [5] Factors That Impact Work Productivity in the Preserve Trial: A Randomized Controlled Trial of Combination Etanercept-Methotrexate Therapy in Patients with Moderately Active Rheumatoid Arthritis.
    Strand, Vibeke
    Jones, Thomas V.
    Li, Wenzhi
    Koenig, Andrew S.
    Kotak, Sameer
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S777 - S777
  • [6] Impact of Etanercept-Methotrexate Therapy On Patient-Reported Outcomes in Rheumatoid Arthritis Patients with up to 12 Months of Symptoms.
    Emery, Paul
    Wiland, Piotr
    Spieler, Wolfgang
    Dudler, Jean
    Gaylord, Stefanie
    Williams, Theresa
    Pedersen, Ronald
    Koenig, Andrew S.
    Vlahos, Bonnie
    Kotak, Sameer
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S160 - S160
  • [7] Patient-reported health outcomes in a trial of etanercept monotherapy versus combination therapy with etanercept and methotrexate for rheumatoid arthritis: the ADORE trial
    van Riel, P. L. C. M.
    Freundlich, B.
    MacPeek, D.
    Pedersen, R.
    Foehl, J. R.
    Singh, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (08) : 1104 - 1110
  • [8] IMPACT OF ETANERCEPT-METHOTREXATE THERAPY ON DISEASE ACTIVITY IN MODERATELY ACTIVE RHEUMATOID ARTHRITIS: INTERIM OVERALL AND AUSTRALIAN RESULTS FROM THE PRESERVE TRIAL
    Nash, P.
    Hall, S.
    Will, R.
    Smith, M.
    Buchanan, R.
    Smolen, J.
    Thirunavukkarasu, K.
    Marshall, L.
    Hammond, C.
    Vlahos, B.
    Pedersen, R.
    Koenig, A.
    INTERNAL MEDICINE JOURNAL, 2011, 41 : 20 - 20
  • [9] Baseline Predictors of Remission with Combination Etanercept-Methotrexate Therapy in Moderately Active Rheumatoid Arthritis: Interim Results of the PRESERVE Trial
    Smolen, Josef
    Szumski, Annette
    Marshall, Lisa
    Koenig, Andrew S.
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S474 - S474
  • [10] Patient reported outcomes in a trial of combination therapy with etanercept and methotrexate for rheumatoid arthritis: the TEMPO trial
    van der Heijde, D
    Klareskog, L
    Singh, A
    Tornero, J
    Melo-Gomes, J
    Codreanu, C
    Pedersen, R
    Freundlich, B
    Fatenejad, S
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (03) : 328 - 334
12345